Activity of Gut-Derived Nisin-like Lantibiotics against Human Gut Pathogens and Commensals
Open Access
- 31 January 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 19 (2) , 357-369
Abstract
Recent advances in sequencing techniques unveiled the vast potential of ribosomally synthesized and post-translationally modified peptides (RiPPs) encoded in microbiomes. Class I lantibiotics such as nisin A, widely used as a food preservative, have been investigated for their efficacy in killing pathogens. However, the impact of nisin and nisin-like class I lantibiotics on commensal bacteria residing in the human gut remains unclear. Here, we report six gut-derived class I lantibiotics that are close homologues of nisin, four of which are novel. We applied an improved lantibiotic expression platform to produce and purify these lantibiotics for antimicrobial assays. We determined their minimal inhibitory concentration (MIC) against both Gram-positive human pathogens and gut commensals and profiled the lantibiotic resistance genes in these pathogens and commensals. Structure-activity relationship (SAR) studies with analogs revealed key regions and residues that impact their antimicrobial properties. Our characterization and SAR studies of nisin-like lantibiotics against both pathogens and human gut commensals could shed light on the future development of lantibiotic-based therapeutics and food preservatives.Keywords
Funding Information
- Howard Hughes Medical Institute
- National Cancer Institute (P01 CA023766)
- National Institute of Allergy and Infectious Diseases (R01 AI042135, R01AI095706, U01 AI124275)
- The GI Research Foundation
- Duchossois Family Institute, University of Chicago
- Life Science Research Foundation
This publication has 62 references indexed in Scilit:
- Ribosomally Synthesized and Post‐Translationally Modified Peptide Natural Products: New Insights into the Role of Leader and Core Peptides during BiosynthesisChemistry – A European Journal, 2013
- Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclatureNatural Product Reports, 2012
- The spiFEG Locus in Streptococcus infantarius subsp. infantarius BAA-102 Confers Protection against Nisin UAntimicrobial Agents and Chemotherapy, 2012
- The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficileMicrobiology, 2011
- Peptide Antibiotic Sensing and Detoxification Modules of Bacillus subtilisAntimicrobial Agents and Chemotherapy, 2011
- TelA Contributes to the Innate Resistance of Listeria monocytogenes to Nisin and Other Cell Wall-Acting AntibioticsAntimicrobial Agents and Chemotherapy, 2010
- Novel Mechanism for Nisin Resistance via Proteolytic Degradation of Nisin by the Nisin Resistance Protein NSRAntimicrobial Agents and Chemotherapy, 2009
- The generation of nisin variants with enhanced activity against specific Gram‐positive pathogensMolecular Microbiology, 2008
- Assembly and Stability of Nisin−Lipid II PoresBiochemistry, 2004
- Function of Lactococcus lactis Nisin Immunity Genes nisI and nisFEG after Coordinated Expression in the Surrogate Host Bacillus subtilisJournal of Biological Chemistry, 2003